Lobby organisation
LEO Pharma A/S
Company · Health & pharma · HQ: Denmark · Transparency Register entry
As of 7 November 2026, LEO Pharma A/S appears in 4 declared MEP meetings (4 different MEPs), most often with Renew Europe.
In their own words
“LEO Pharma is a global leader in medical dermatology. We deliver innovative solutions for skin health, building on a century of experience with breakthrough medicines in healthcare. We are committed to making a fundamental difference in people’s lives, and our broad portfolio of treatments serves close to 100 million patients in over 70 countries annually.”
Read the rest of the statementShow less of the statement
“Headquartered in Denmark, LEO Pharma has a team of 4,000 people worldwide. LEO Pharma is co-owned by majority shareholder the LEO Foundation and, since 2021, Nordic Capital. For more information, visit www.leo-pharma.com.”
Stated goals from the organisation's own Transparency Register filing.
Who they meet, and when
Which groups they meet
Share of this organisation's 4 declared meetings, by the meeting MEP's political group.
Meetings by year
Declared meetings per calendar year, 2026–2026. Bar length is relative to its busiest year (4 in 2026). All meetings were in one calendar year. Hatched: 2026 is a part-year - the record runs to 6 Nov 2026.
Group is each MEP's current political group, not necessarily the one they sat with at the time. Shares are rounded to whole percent.
The MEPs they meet most
The 4 most recent declared meetings
| Date | MEP | Subject |
|---|---|---|
| 24 Jun 2026 | Morten Løkkegaard | Biotech |
| 24 Jun 2026 | Henrik Dahl | Medical devices |
| 9 Jun 2026 | Kristoffer Storm | EU Biotech Act |
| 22 Apr 2026 | Stine Bosse | Biotech Act |
Meeting an MEP is a normal part of democratic life; the record is shown so anyone can see it.